This inventor holds 2 USPTO granted patents. Top assignee: Virtech Bio, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Innovations in Blood Substitutes by Joseph Tucker
Introduction
Joseph Tucker is an accomplished inventor based in Natick, MA (US). He has made significant contributions to the field of blood substitutes, holding a total of 2 patents. His work focuses on developing methods for creating hemoglobin-based blood substitute preparations.
Latest Patents
Tucker's latest patents include innovative methods for making hemoglobin-based blood substitute preparations. These methods involve preparing a low purity erythrocyte protein fraction that comprises hemoglobin protein and endogenous non-hemoglobin protein complement. The process includes chemically modifying the proteins in the protein fraction to create a cross-linked hemoglobin-containing blood substitute preparation. The erythrocyte protein preparation can contain between 0.2% and 20% of the endogenous non-hemoglobin protein complement. Notably, at least 90% of the hemoglobin proteins can be cross-linked, resulting in an average molecular mass of cross-linked proteins of at least 300 kDa. These preparations are designed for use in finished blood substitute formulations for both in-vivo and ex-vivo applications.
Career Highlights
Joseph Tucker is currently associated with Virtech Bio, Inc., where he continues to advance his research in blood substitutes. His innovative approaches have the potential to revolutionize the medical field by providing effective alternatives to traditional blood transfusions.
Collaborations
Tucker collaborates with William Richard Light, contributing to the development of cutting-edge solutions in the field of blood substitutes.
Conclusion
Joseph Tucker's work in developing hemoglobin-based blood substitutes represents a significant advancement in medical technology. His innovative methods and collaborations are paving the way for new treatments that could save lives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile